Middle East & Africa Infectious Disease In vitro Diagnostics Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Application (HIV or AIDS, Tuberculosis, Hepatitis B and C, Malaria, and Others) and End User (Hospitals and Clinics, Diagnostic Laboratories, Blood Bank, and Others)
The Middle East & Africa Infectious Disease In Vitro Diagnostics (IVD) Market is projected to experience significant growth, with an expected market size of approximately US$ 2,391.5 million by 2031, up from US$ 1,526.0 million in 2024. This growth translates to a compound annual growth rate (CAGR) of 6.7% from 2025 to 2031.
Executive Summary
The IVD market for infectious diseases in the Middle East & Africa, particularly in key countries such as the UAE, Saudi Arabia, and South Africa, is poised for substantial expansion in the coming years. This growth is driven by several factors, including advancements in healthcare infrastructure, supportive government initiatives, and enhanced international collaborations aimed at improving diagnostic capabilities. Saudi Arabia and the UAE are leading this growth trajectory by investing heavily in healthcare and technological advancements. Meanwhile, South Africa is witnessing market development through the introduction of new products, public-private partnerships, and government support for healthcare innovation.
The rising incidence of infectious diseases and the demand for reliable, cost-effective, and rapid IVD solutions are awakening the region to the critical importance of diagnostics. The ongoing modernization of the healthcare sector and a focus on early disease detection are expected to further accelerate the adoption of IVD technologies across the region.
Market Segmentation
The Middle East & Africa Infectious Disease IVD Market is segmented by application and end-user. In terms of applications, the market includes categories such as HIV/AIDS, Tuberculosis, Hepatitis B and C, Malaria, and others. Notably, Hepatitis B and C are projected to hold the largest market share in 2024.
By end-user, the market is divided into Hospitals and Clinics, Diagnostic Laboratories, Blood Banks, and others, with Hospitals and Clinics also expected to dominate the market share in 2024.
Market Outlook
According to the World Health Organization (WHO), tuberculosis (TB) affects around 10 million people globally each year, resulting in approximately 1.5 million deaths annually. Despite being preventable and treatable, TB remains one of the leading infectious disease killers worldwide, particularly in low- and middle-income countries. The prevalence of HIV is also on the rise, with an estimated 39.9 million individuals living with the virus as of the end of 2023. This epidemic varies significantly across different regions, highlighting the urgent need for effective diagnostic solutions.
Additionally, the increasing incidence of fungal infections poses a significant health risk, with over 80 million people at high risk of developing such diseases annually. The Global Action Fund for Fungal Infections (GAFFI) reports that approximately 6.55 million patients develop life-threatening fungal infections each year, leading to around 3.75 million deaths. This alarming trend underscores the critical need for in vitro diagnostics to facilitate early detection and treatment of infectious diseases.
The rising prevalence of infectious diseases such as HIV, hepatitis, tuberculosis, and influenza is driving demand for rapid and accurate diagnostic solutions. Innovations in molecular diagnostics, improved point-of-care testing, and a greater emphasis on early detection and disease surveillance are collectively propelling the adoption of IVD methodologies across both developed and emerging healthcare markets.
Country Insights
The market is further segmented by country, with significant contributions from South Africa, Saudi Arabia, the UAE, and the Rest of the Middle East & Africa. Saudi Arabia is expected to hold the largest market share in 2024, benefiting from increased healthcare investments aligned with the Kingdom's Vision 2030 initiative. Health expenditure in Saudi Arabia is projected to grow by 3% annually from 2022 to 2025, aimed at enhancing public hospitals, clinical laboratories, and modern diagnostic facilities.
The demand for IVD solutions, particularly for infectious diseases and oncology, is accelerating due to rising investments from both public and private sectors. Vision 2030 is also facilitating a strategic decentralization of healthcare services, shifting diagnostic capabilities from tertiary hospitals to primary and community care centers, thereby improving access and enabling earlier detection of critical health conditions.
Despite these advancements, challenges remain, particularly in diagnostic coverage for essential infectious diseases. For instance, only 10.45% of hepatitis B cases and 43% of hepatitis C cases were diagnosed in 2022, indicating a significant gap in healthcare delivery.
Key Players
Key players in the Middle East & Africa Infectious Disease IVD Market include Abbott Laboratories, F. Hoffmann-La Roche Ltd, Sysmex Corp, bioMerieux SA, Bio-Rad Laboratories Inc, QIAGEN NV, Bruker Corp, QuidelOrtho Corp, Becton, Dickinson and Co, and Danaher Corp. These companies are actively pursuing strategies such as expansion, product innovation, and mergers and acquisitions to enhance their market presence and offer innovative solutions to consumers.
Executive Summary
The IVD market for infectious diseases in the Middle East & Africa, particularly in key countries such as the UAE, Saudi Arabia, and South Africa, is poised for substantial expansion in the coming years. This growth is driven by several factors, including advancements in healthcare infrastructure, supportive government initiatives, and enhanced international collaborations aimed at improving diagnostic capabilities. Saudi Arabia and the UAE are leading this growth trajectory by investing heavily in healthcare and technological advancements. Meanwhile, South Africa is witnessing market development through the introduction of new products, public-private partnerships, and government support for healthcare innovation.
The rising incidence of infectious diseases and the demand for reliable, cost-effective, and rapid IVD solutions are awakening the region to the critical importance of diagnostics. The ongoing modernization of the healthcare sector and a focus on early disease detection are expected to further accelerate the adoption of IVD technologies across the region.
Market Segmentation
The Middle East & Africa Infectious Disease IVD Market is segmented by application and end-user. In terms of applications, the market includes categories such as HIV/AIDS, Tuberculosis, Hepatitis B and C, Malaria, and others. Notably, Hepatitis B and C are projected to hold the largest market share in 2024.
By end-user, the market is divided into Hospitals and Clinics, Diagnostic Laboratories, Blood Banks, and others, with Hospitals and Clinics also expected to dominate the market share in 2024.
Market Outlook
According to the World Health Organization (WHO), tuberculosis (TB) affects around 10 million people globally each year, resulting in approximately 1.5 million deaths annually. Despite being preventable and treatable, TB remains one of the leading infectious disease killers worldwide, particularly in low- and middle-income countries. The prevalence of HIV is also on the rise, with an estimated 39.9 million individuals living with the virus as of the end of 2023. This epidemic varies significantly across different regions, highlighting the urgent need for effective diagnostic solutions.
Additionally, the increasing incidence of fungal infections poses a significant health risk, with over 80 million people at high risk of developing such diseases annually. The Global Action Fund for Fungal Infections (GAFFI) reports that approximately 6.55 million patients develop life-threatening fungal infections each year, leading to around 3.75 million deaths. This alarming trend underscores the critical need for in vitro diagnostics to facilitate early detection and treatment of infectious diseases.
The rising prevalence of infectious diseases such as HIV, hepatitis, tuberculosis, and influenza is driving demand for rapid and accurate diagnostic solutions. Innovations in molecular diagnostics, improved point-of-care testing, and a greater emphasis on early detection and disease surveillance are collectively propelling the adoption of IVD methodologies across both developed and emerging healthcare markets.
Country Insights
The market is further segmented by country, with significant contributions from South Africa, Saudi Arabia, the UAE, and the Rest of the Middle East & Africa. Saudi Arabia is expected to hold the largest market share in 2024, benefiting from increased healthcare investments aligned with the Kingdom's Vision 2030 initiative. Health expenditure in Saudi Arabia is projected to grow by 3% annually from 2022 to 2025, aimed at enhancing public hospitals, clinical laboratories, and modern diagnostic facilities.
The demand for IVD solutions, particularly for infectious diseases and oncology, is accelerating due to rising investments from both public and private sectors. Vision 2030 is also facilitating a strategic decentralization of healthcare services, shifting diagnostic capabilities from tertiary hospitals to primary and community care centers, thereby improving access and enabling earlier detection of critical health conditions.
Despite these advancements, challenges remain, particularly in diagnostic coverage for essential infectious diseases. For instance, only 10.45% of hepatitis B cases and 43% of hepatitis C cases were diagnosed in 2022, indicating a significant gap in healthcare delivery.
Key Players
Key players in the Middle East & Africa Infectious Disease IVD Market include Abbott Laboratories, F. Hoffmann-La Roche Ltd, Sysmex Corp, bioMerieux SA, Bio-Rad Laboratories Inc, QIAGEN NV, Bruker Corp, QuidelOrtho Corp, Becton, Dickinson and Co, and Danaher Corp. These companies are actively pursuing strategies such as expansion, product innovation, and mergers and acquisitions to enhance their market presence and offer innovative solutions to consumers.
1. INTRODUCTION
1.1 Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
3. RESEARCH METHODOLOGY
3.1 Secondary Research
3.1 Primary Research
3.1.1 Hypothesis formulation:
3.1.2 Macro-economic factor analysis:
3.1.3 Developing base number:
3.1.4 Data Triangulation:
3.1.5 Country level data:
3.2 Assumptions and Limitations
4. INFECTIOUS DISEASE IN VITRO DIAGNOSTICS MARKET LANDSCAPE
4.1 Overview
4.2 PEST Analysis
5. MIDDLE EAST & AFRICA INFECTIOUS DISEASE IN VITRO DIAGNOSTICS MARKET - KEY MARKET DYNAMICS
5.1 Market Drivers
5.1.1 Increasing Prevalence of Infectious Diseases
5.1.2 Strategic Developments by Key Players
5.2 Market Restraints
5.2.1 Inadequate Reimbursement Scenario
5.3 Market Opportunities
5.3.1 Government Initiatives to Increase Awareness Regarding Infectious Diseases
5.4 Future Trends
5.4.1 Technological Advancements
5.5 Impact of Drivers and Restraints:
6. INFECTIOUS DISEASE IN VITRO DIAGNOSTICS MARKET - MIDDLE EAST & AFRICA ANALYSIS
6.1 Middle East & Africa Infectious Disease In vitro Diagnostics Market Revenue (US$ Million), 2021-2031
6.2 Middle East & Africa Infectious Disease In vitro Diagnostics Market Forecast Analysis
7. MIDDLE EAST & AFRICA INFECTIOUS DISEASE IN VITRO DIAGNOSTICS MARKET ANALYSIS - BY APPLICATIONS
7.1 HIV or AIDS
7.1.1 Overview
7.1.2 HIV or AIDS: Middle East & Africa Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Tuberculosis
7.2.1 Overview
7.2.2 Tuberculosis: Middle East & Africa Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.3 Hepatitis B and C
7.3.1 Overview
7.3.2 Hepatitis B and C: Middle East & Africa Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.4 Malaria
7.4.1 Overview
7.4.2 Malaria: Middle East & Africa Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: Middle East & Africa Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
8. MIDDLE EAST & AFRICA INFECTIOUS DISEASE IN VITRO DIAGNOSTICS MARKET ANALYSIS - BY END USER
8.1 Hospitals and Clinics
8.1.1 Overview
8.1.2 Hospitals and Clinics: Middle East & Africa Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Diagnostic Laboratories
8.2.1 Overview
8.2.2 Diagnostic Laboratories: Middle East & Africa Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.3 Blood Bank
8.3.1 Overview
8.3.2 Blood Bank: Middle East & Africa Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.4 Others
8.4.1 Overview
8.4.2 Others: Middle East & Africa Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
9. MIDDLE EAST & AFRICA INFECTIOUS DISEASE IN VITRO DIAGNOSTICS MARKET - COUNTRY ANALYSIS
9.1 Middle East & Africa
9.1.1 Middle East & Africa Infectious Disease In vitro Diagnostics Market - Revenue and Forecast Analysis - by Country
9.1.1.1 Middle East & Africa Infectious Disease In vitro Diagnostics Market - Revenue and Forecast Analysis - by Country
9.1.1.2 South Africa: Middle East & Africa Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.1.1.2.1 South Africa: Middle East & Africa Infectious Disease In vitro Diagnostics Market Share - by Applications
9.1.1.2.2 South Africa: Middle East & Africa Infectious Disease In vitro Diagnostics Market Share - by End User
9.1.1.3 Saudi Arabia: Middle East & Africa Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.1.1.3.1 Saudi Arabia: Middle East & Africa Infectious Disease In vitro Diagnostics Market Share - by Applications
9.1.1.3.2 Saudi Arabia: Middle East & Africa Infectious Disease In vitro Diagnostics Market Share - by End User
9.1.1.4 United Arab Emirates: Middle East & Africa Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.1.1.4.1 United Arab Emirates: Middle East & Africa Infectious Disease In vitro Diagnostics Market Share - by Applications
9.1.1.4.2 United Arab Emirates: Middle East & Africa Infectious Disease In vitro Diagnostics Market Share - by End User
9.1.1.5 Rest of Middle East & Africa: Middle East & Africa Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.1.1.5.1 Rest of Middle East & Africa: Middle East & Africa Infectious Disease In vitro Diagnostics Market Share - by Applications
9.1.1.5.2 Rest of Middle East & Africa: Middle East & Africa Infectious Disease In vitro Diagnostics Market Share - by End User
10. COMPETITIVE LANDSCAPE
10.1 Heat Map Analysis by Key Players
10.2 Company Positioning & Concentration
11. INDUSTRY LANDSCAPE
11.1 Overview
11.2 Growth Strategies in the Global Infectious Disease In-Vitro Diagnostics Market
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies
11.4.1 Overview
12. COMPANY PROFILES
12.1 Abbott Laboratories
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 F. Hoffmann-La Roche Ltd
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Becton Dickinson and Co
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Sysmex Corp
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.5 bioMerieux SA
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Bio-Rad Laboratories Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 QIAGEN NV
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 QuidelOrtho Corp
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Bruker Corp
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Danaher Corp
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. APPENDIX
13.1 About The Insight Partners
13.2 Glossary of Terms
1.1 Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
3. RESEARCH METHODOLOGY
3.1 Secondary Research
3.1 Primary Research
3.1.1 Hypothesis formulation:
3.1.2 Macro-economic factor analysis:
3.1.3 Developing base number:
3.1.4 Data Triangulation:
3.1.5 Country level data:
3.2 Assumptions and Limitations
4. INFECTIOUS DISEASE IN VITRO DIAGNOSTICS MARKET LANDSCAPE
4.1 Overview
4.2 PEST Analysis
5. MIDDLE EAST & AFRICA INFECTIOUS DISEASE IN VITRO DIAGNOSTICS MARKET - KEY MARKET DYNAMICS
5.1 Market Drivers
5.1.1 Increasing Prevalence of Infectious Diseases
5.1.2 Strategic Developments by Key Players
5.2 Market Restraints
5.2.1 Inadequate Reimbursement Scenario
5.3 Market Opportunities
5.3.1 Government Initiatives to Increase Awareness Regarding Infectious Diseases
5.4 Future Trends
5.4.1 Technological Advancements
5.5 Impact of Drivers and Restraints:
6. INFECTIOUS DISEASE IN VITRO DIAGNOSTICS MARKET - MIDDLE EAST & AFRICA ANALYSIS
6.1 Middle East & Africa Infectious Disease In vitro Diagnostics Market Revenue (US$ Million), 2021-2031
6.2 Middle East & Africa Infectious Disease In vitro Diagnostics Market Forecast Analysis
7. MIDDLE EAST & AFRICA INFECTIOUS DISEASE IN VITRO DIAGNOSTICS MARKET ANALYSIS - BY APPLICATIONS
7.1 HIV or AIDS
7.1.1 Overview
7.1.2 HIV or AIDS: Middle East & Africa Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Tuberculosis
7.2.1 Overview
7.2.2 Tuberculosis: Middle East & Africa Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.3 Hepatitis B and C
7.3.1 Overview
7.3.2 Hepatitis B and C: Middle East & Africa Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.4 Malaria
7.4.1 Overview
7.4.2 Malaria: Middle East & Africa Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: Middle East & Africa Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
8. MIDDLE EAST & AFRICA INFECTIOUS DISEASE IN VITRO DIAGNOSTICS MARKET ANALYSIS - BY END USER
8.1 Hospitals and Clinics
8.1.1 Overview
8.1.2 Hospitals and Clinics: Middle East & Africa Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Diagnostic Laboratories
8.2.1 Overview
8.2.2 Diagnostic Laboratories: Middle East & Africa Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.3 Blood Bank
8.3.1 Overview
8.3.2 Blood Bank: Middle East & Africa Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.4 Others
8.4.1 Overview
8.4.2 Others: Middle East & Africa Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
9. MIDDLE EAST & AFRICA INFECTIOUS DISEASE IN VITRO DIAGNOSTICS MARKET - COUNTRY ANALYSIS
9.1 Middle East & Africa
9.1.1 Middle East & Africa Infectious Disease In vitro Diagnostics Market - Revenue and Forecast Analysis - by Country
9.1.1.1 Middle East & Africa Infectious Disease In vitro Diagnostics Market - Revenue and Forecast Analysis - by Country
9.1.1.2 South Africa: Middle East & Africa Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.1.1.2.1 South Africa: Middle East & Africa Infectious Disease In vitro Diagnostics Market Share - by Applications
9.1.1.2.2 South Africa: Middle East & Africa Infectious Disease In vitro Diagnostics Market Share - by End User
9.1.1.3 Saudi Arabia: Middle East & Africa Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.1.1.3.1 Saudi Arabia: Middle East & Africa Infectious Disease In vitro Diagnostics Market Share - by Applications
9.1.1.3.2 Saudi Arabia: Middle East & Africa Infectious Disease In vitro Diagnostics Market Share - by End User
9.1.1.4 United Arab Emirates: Middle East & Africa Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.1.1.4.1 United Arab Emirates: Middle East & Africa Infectious Disease In vitro Diagnostics Market Share - by Applications
9.1.1.4.2 United Arab Emirates: Middle East & Africa Infectious Disease In vitro Diagnostics Market Share - by End User
9.1.1.5 Rest of Middle East & Africa: Middle East & Africa Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.1.1.5.1 Rest of Middle East & Africa: Middle East & Africa Infectious Disease In vitro Diagnostics Market Share - by Applications
9.1.1.5.2 Rest of Middle East & Africa: Middle East & Africa Infectious Disease In vitro Diagnostics Market Share - by End User
10. COMPETITIVE LANDSCAPE
10.1 Heat Map Analysis by Key Players
10.2 Company Positioning & Concentration
11. INDUSTRY LANDSCAPE
11.1 Overview
11.2 Growth Strategies in the Global Infectious Disease In-Vitro Diagnostics Market
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies
11.4.1 Overview
12. COMPANY PROFILES
12.1 Abbott Laboratories
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 F. Hoffmann-La Roche Ltd
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Becton Dickinson and Co
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Sysmex Corp
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.5 bioMerieux SA
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Bio-Rad Laboratories Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 QIAGEN NV
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 QuidelOrtho Corp
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Bruker Corp
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Danaher Corp
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. APPENDIX
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Middle East & Africa Infectious Disease In vitro Diagnostics Market Segmentation
Table 2. Middle East & Africa Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Table 3. Middle East & Africa Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Applications
Table 4. Middle East & Africa Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million) - by End User
Table 5. Middle East & Africa Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Country
Table 6. South Africa: Middle East & Africa Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Applications
Table 7. South Africa: Middle East & Africa Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by End User
Table 8. Saudi Arabia: Middle East & Africa Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Applications
Table 9. Saudi Arabia: Middle East & Africa Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by End User
Table 10. United Arab Emirates: Middle East & Africa Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Applications
Table 11. United Arab Emirates: Middle East & Africa Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by End User
Table 12. Rest of Middle East & Africa: Middle East & Africa Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Applications
Table 13. Rest of Middle East & Africa: Middle East & Africa Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by End User
Table 14. Heat Map Analysis by Key Players
Table 15. Recent Organic Growth Strategies in the global Infectious Disease In-Vitro Diagnostics Market
Table 16. Recent Inorganic Growth Strategies in the Global Infectious Disease In-Vitro Diagnostics Market
Table 17. Glossary of Terms, Infectious Disease In vitro Diagnostics Market
Table 1. Middle East & Africa Infectious Disease In vitro Diagnostics Market Segmentation
Table 2. Middle East & Africa Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Table 3. Middle East & Africa Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Applications
Table 4. Middle East & Africa Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million) - by End User
Table 5. Middle East & Africa Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Country
Table 6. South Africa: Middle East & Africa Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Applications
Table 7. South Africa: Middle East & Africa Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by End User
Table 8. Saudi Arabia: Middle East & Africa Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Applications
Table 9. Saudi Arabia: Middle East & Africa Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by End User
Table 10. United Arab Emirates: Middle East & Africa Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Applications
Table 11. United Arab Emirates: Middle East & Africa Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by End User
Table 12. Rest of Middle East & Africa: Middle East & Africa Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Applications
Table 13. Rest of Middle East & Africa: Middle East & Africa Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by End User
Table 14. Heat Map Analysis by Key Players
Table 15. Recent Organic Growth Strategies in the global Infectious Disease In-Vitro Diagnostics Market
Table 16. Recent Inorganic Growth Strategies in the Global Infectious Disease In-Vitro Diagnostics Market
Table 17. Glossary of Terms, Infectious Disease In vitro Diagnostics Market
LIST OF FIGURES
Figure 1. Middle East & Africa Infectious Disease In vitro Diagnostics Market Segmentation - Country
Figure 2. PEST Analysis
Figure 3. Middle East & Africa Infectious Disease In vitro Diagnostics Market - Key Market Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. Middle East & Africa Infectious Disease In vitro Diagnostics Market Revenue (US$ Million), 2021-2031
Figure 6. Middle East & Africa Infectious Disease In vitro Diagnostics Market Share (%) - by Applications (2024 and 2031)
Figure 7. HIV or AIDS: Middle East & Africa Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 8. Tuberculosis: Middle East & Africa Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 9. Hepatitis B and C: Middle East & Africa Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 10. Malaria: Middle East & Africa Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 11. Others: Middle East & Africa Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 12. Middle East & Africa Infectious Disease In vitro Diagnostics Market Share (%) - by End User (2024 and 2031)
Figure 13. Hospitals and Clinics: Middle East & Africa Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 14. Diagnostic Laboratories: Middle East & Africa Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 15. Blood Bank: Middle East & Africa Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 16. Others: Middle East & Africa Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 17. Middle East & Africa Infectious Disease In vitro Diagnostics Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 18. South Africa: Middle East & Africa Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021- 2031 (US$ Million)
Figure 19. Saudi Arabia: Middle East & Africa Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021- 2031 (US$ Million)
Figure 20. United Arab Emirates: Middle East & Africa Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021- 2031 (US$ Million)
Figure 21. Rest of Middle East & Africa: Middle East & Africa Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021- 2031 (US$ Million)
Figure 22. Company Positioning & Concentration
Figure 23. Growth Strategies in the Global Infectious Disease In-Vitro Diagnostics Market
Figure 1. Middle East & Africa Infectious Disease In vitro Diagnostics Market Segmentation - Country
Figure 2. PEST Analysis
Figure 3. Middle East & Africa Infectious Disease In vitro Diagnostics Market - Key Market Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. Middle East & Africa Infectious Disease In vitro Diagnostics Market Revenue (US$ Million), 2021-2031
Figure 6. Middle East & Africa Infectious Disease In vitro Diagnostics Market Share (%) - by Applications (2024 and 2031)
Figure 7. HIV or AIDS: Middle East & Africa Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 8. Tuberculosis: Middle East & Africa Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 9. Hepatitis B and C: Middle East & Africa Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 10. Malaria: Middle East & Africa Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 11. Others: Middle East & Africa Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 12. Middle East & Africa Infectious Disease In vitro Diagnostics Market Share (%) - by End User (2024 and 2031)
Figure 13. Hospitals and Clinics: Middle East & Africa Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 14. Diagnostic Laboratories: Middle East & Africa Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 15. Blood Bank: Middle East & Africa Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 16. Others: Middle East & Africa Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 17. Middle East & Africa Infectious Disease In vitro Diagnostics Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 18. South Africa: Middle East & Africa Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021- 2031 (US$ Million)
Figure 19. Saudi Arabia: Middle East & Africa Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021- 2031 (US$ Million)
Figure 20. United Arab Emirates: Middle East & Africa Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021- 2031 (US$ Million)
Figure 21. Rest of Middle East & Africa: Middle East & Africa Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021- 2031 (US$ Million)
Figure 22. Company Positioning & Concentration
Figure 23. Growth Strategies in the Global Infectious Disease In-Vitro Diagnostics Market
